New data from the MEL-SELF trial show gaps in melanoma self-surveillance confidence, highlighting opportunities to improve ...
Dermoscopy can noninvasively identify immune checkpoint inhibitor (ICI)–related skin toxicities early in patients with ...
Use of artificial intelligence to identify high risk profiles in early stage melanoma patients from pathology slides. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
A simple skin patch and COVID-like test could soon allow people to test for melanoma in the comfort of their home—helping catch the most dangerous type of skin cancer early without the need for a ...
Melanoma usually appears in locations where the skin receives frequent sun exposure, like the face, neck, shoulders, arms and legs. These melanomas are often linked to ultraviolet (UV) damage and may ...
Anxiety, depression, fear of cancer recurrence (FCR) and health-related quality of life (HRQL) in people with melanoma receiving adjuvant therapies. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Among all patients studied, 2.6% nodal positivity and 97.8% three-year recurrence-free survival (RFS) was observed in those predicted to have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results